Literature DB >> 12652381

Risk factors for primary bacteremia and endovascular infection in patients without acquired immunodeficiency syndrome who have nontyphoid salmonellosis.

Ron-Bin Hsu1, Yeou-Guang Tsay, Robert J Chen, Shu-Hsun Chu.   

Abstract

This study sought to find the risk factors for primary bacteremia, endovascular infection, and in-hospital death for patients without acquired immunodeficiency syndrome who have nontyphoid salmonellosis. From September 1995 through September 2001, 301 patients with nontyphoid salmonellosis were admitted to our hospital; of these patients, 121 had primary bacteremia, and 28 had endovascular infection. Of the 121 patients with primary bacteremia, 64 were aged >50 years, and 26 had endovascular infection. Overall, 90 patients (29.9%) had immunodeficiency. Predictors of primary bacteremia were age; presence of systemic lupus erythematosus; group B, group C, or group D Salmonella infection; and immunodeficiency. The positive predictor of endovascular infection in adult patients with primary bacteremia was group C Salmonella infection, and negative predictors were immunodeficiency and solid-organ cancer. The overall in-hospital mortality rate was 12%; for primary bacteremia, it was 24.8%; for endovascular infection, it was 14.3%. Predictors of in-hospital death were age, extraintestinal infection, and solid-organ malignancy.

Entities:  

Mesh:

Year:  2003        PMID: 12652381     DOI: 10.1086/367932

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

1.  Reply to Chien et al.

Authors:  Po-Lin Chen; Hung-Jen Tang; Wen-Chien Ko
Journal:  Clin Infect Dis       Date:  2012-09-28       Impact factor: 9.079

Review 2.  Nontyphoidal cardiac salmonellosis: two case reports and a review of the literature.

Authors:  Daniel Ortiz; Eric M Siegal; Christopher Kramer; Bijoy K Khandheria; Ernesto Brauer
Journal:  Tex Heart Inst J       Date:  2014-08-01

3.  Bacteraemia due to ciprofloxacin-resistant Salmonella enterica serotype Choleraesuis in adult patients at a university hospital in Taiwan, 1996-2004.

Authors:  J-Y Wang; J-J Hwang; C-N Hsu; L-C Lin; P-R Hsueh
Journal:  Epidemiol Infect       Date:  2006-03-29       Impact factor: 2.451

4.  Primary Infected Aortic Aneurysm: Clinical Presentation, Pathogen, and Outcome.

Authors:  Cheng-Hsin Lin; Ron-Bin Hsu
Journal:  Acta Cardiol Sin       Date:  2014-11       Impact factor: 2.672

5.  Epidemiology and Outcomes of Nontyphoidal Salmonella Bacteremias from England, 2004 to 2015.

Authors:  Shannon Katiyo; Berit Muller-Pebody; Mehdi Minaji; David Powell; Alan P Johnson; Elizabeth De Pinna; Martin Day; Ross Harris; Gauri Godbole
Journal:  J Clin Microbiol       Date:  2019-01-02       Impact factor: 5.948

6.  Salmonella aortitis treated with endovascular aortic repair: a case report.

Authors:  Carol Strahm; Heidi Lederer; Esther I Schwarz; Esther B Bachli
Journal:  J Med Case Rep       Date:  2012-08-15

7.  Salmonella enterica serovars associated with bacteremia in Canada, 2006-2019.

Authors:  Sandeep Tamber; Brendan Dougherty; Kimberly Nguy
Journal:  Can Commun Dis Rep       Date:  2021-06-09

8.  A retrospective study of secondary bacteraemia in hospitalised adults with community acquired non-typhoidal Salmonella gastroenteritis.

Authors:  Christopher M Parry; Sherine Thomas; Esther J Aspinall; Richard P D Cooke; Stephen J Rogerson; Anthony D Harries; Nicholas J Beeching
Journal:  BMC Infect Dis       Date:  2013-02-27       Impact factor: 3.090

9.  Increased non-typhoidal Salmonella hospitalizations in transfusion-naïve thalassemia children: a nationwide population-based cohort study.

Authors:  Jiunn-Ming Sheen; Fang-Ju Lin; Yao-Hsu Yang; Kuang-Che Kuo
Journal:  Pediatr Res       Date:  2021-06-19       Impact factor: 3.953

10.  First Case of Lung Abscess due to Salmonella enterica Serovar Abony in an Immunocompetent Adult Patient.

Authors:  Vassiliki Pitiriga; John Dendrinos; Emanuel Nikitiadis; Georgia Vrioni; Athanassios Tsakris
Journal:  Case Rep Infect Dis       Date:  2016-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.